| Announce Date | 11/10/2025 |
| EPS Normalized Actual | $-0.12 In Line |
| EPS GAAP Actual | $-0.12 In Line |
| Revenue Actual | $0.000217B |
| Revenue Surprise | Beat by $0.217M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $-0.13545 |
| EPS GAAP Estimate | $-0.13545 |
| Revenue Estimate | $-7.6667E-5B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | -0.19 | -12.37 | -0.19 | -0.19 | 1 |
| Dec 2028 | -0.32 | -7.34 | -0.32 | -0.32 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.12 | 0.025 | 0.000217B | 100% | 0.14M |
| FQ2 2025 (Jun 2025) | -0.13 | 0.015 | 0.000221B | 100% | 0.15M |
| FQ1 2025 (Mar 2025) | -0.13 | 0.05 | 0.00023B | 100% | 0.23M |
| FQ4 2024 (Dec 2024) | -0.17 | 0.23 | 7.6E-5B | 100% | 0.08M |
| FQ4 2020 (Dec 2020) | -0.0661 | -0.0661 | 0B | NAN% | 0M |
| FQ3 2024 (Sep 2024) | -0.18 | 0.205 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | -0.16 | -1.50259 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | -0.16 | -1.73645 | 0B | NAN% | 0M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.13545
Consensus Revenue Estimates
-7.6667E-5B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.17 | -- | -0.17 | -0.17 | 1 |
| FQ3 2026 (Sep 2026) | -0.16 | 25 | -0.16 | -0.16 | 1 |
| FQ2 2026 (Jun 2026) | -0.17 | 23.53 | -0.17 | -0.17 | 1 |
| FQ1 2026 (Mar 2026) | -0.09 | -44.44 | -0.801 | 0.387 | 1 |
| FQ4 2025 (Dec 2025) | -0.13545 | -25.51 | -0.13545 | -0.12314 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 2 |
| FQ3 2026 (Sep 2026) | 0B | 0 | 0B | 0B | 2 |
| FQ2 2026 (Jun 2026) | 0B | -1.84 | 0B | 0B | 2 |
| FQ1 2026 (Mar 2026) | 0B | -5.99 | -0B | 0B | 2 |
| FQ4 2025 (Dec 2025) | -0B | 199.13 | -0B | -0B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
0
Revenue # of in-lines
4
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.145 | -0.12 | 0.025 | -20.83% |
| FQ2 2025 (Jun 2025) | -0.145 | -0.13 | 0.015 | -11.54% |
| FQ1 2025 (Mar 2025) | -0.18 | -0.13 | 0.05 | -38.46% |
| FQ4 2024 (Dec 2024) | -0.4 | -0.17 | 0.23 | -135.29% |
| FQ4 2020 (Dec 2020) | -0.0661 | -0.0661 | 100% | |
| FQ3 2024 (Sep 2024) | -0.385 | -0.18 | 0.205 | -113.89% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.16 | -1.50259 | 939.12% |
| FQ1 2024 (Mar 2024) | 1.57645 | -0.16 | -1.73645 | 1085.28% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $0.14M | 64.98% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0.15M | 65.61% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0.23M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0.08M | 100% |
| FQ4 2020 (Dec 2020) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |